Bret Wolter
About Bret Wolter
Bret Wolter is a Research Associate specializing in Cell Therapy Process Development at Bristol Myers Squibb in Seattle, Washington.
Title
Bret Wolter holds the position of Research Associate in the Cell Therapy Process Development (Gene Edited Platform) at Bristol Myers Squibb. In this role, he focuses on the strategic implementation and development of gene-edited cell therapies.
Current Position at Bristol Myers Squibb
Currently based in Seattle, Washington, Bret Wolter works at Bristol Myers Squibb as a Research Associate specializing in Cell Therapy Process Development. His responsibilities include serving as the upstream Subject Matter Expert (SME) and project lead. He is actively involved in platform strategy and the implementation of gene-edited cell therapy processes.
Past Experience at AGC Biologics
Previously, Bret Wolter worked at AGC Biologics as an Upstream Process Development Associate II from 2019 to 2021. During his two-year tenure in Bothell, WA, he gained valuable experience in upstream process development, significantly contributing to the company's bioprocessing projects.
Educational Background
Bret Wolter completed his undergraduate studies at the University of Wisconsin-Madison, obtaining a Bachelor’s degree in Chemical Engineering from 2015 to 2019. During his time at the university, he built a solid foundation in chemical, biological, and technological principles.
Hands-On Experience
Bret Wolter has practical experience in working with CAR-T cell and mammalian cell cultures, catering to both early- and late-stage process development. His role at Bristol Myers Squibb leverages this expertise, where he applies his hands-on skills to advance cell therapy processes.